We have described a novel clinical entity caused by JC virus (JCV) infection of cortical pyramidal neurons in an immunosuppressed individual. This patient presented with lesions restricted to the hemispheric gray matter on MRI, developed aphasia, progressive cognitive dysfunction and seizures and had a rapid fatal outcome. We called this disease JCV encephalopathy (JCVE), since it is distinct from Progressive Multifocal Leukoencephalopathy (PML), caused by JCV infection of glial cells. Post mortem histological evaluation demonstrated for the first time a productive and lytic infection of cortical pyramidal neurons by JCV. We have analyzed the full length sequence of a molecular clone of JCV obtained from the brain of this patient, JCVCPN1, which revealed an archetype-like regulatory region (RR), and a novel 143 bp deletion in the Agnoprotein gene. The CPN mutant was subsequently found in the neurons or cerebrospinal fluid of three other patients with PML. We hypothesize that changes in JCV sequence are responsible for the specific infection of cortical pyramidal neurons in this patient. However, whether JCVCPN1 growth in neurons is made possible by its RR, the novel Agnoprotein deletion, or both, remains unclear. Furthermore, we postulate that JCV infection of cortical neurons may also occur in other individuals, including in PML patients with demyelinating lesions located at the gray white- junction or within the gray matter. Finally, we hypothesize that other pyramidal neurons, located in the hippocampus may also be infected by JCV variants, which could lead to the development of seizures. To test these hypotheses, we will pursue the following set of Specific Aims:
Aim 1) Characterize the host cell range of JCVCPN1 in vitro Aim 2) Determine the contributions of the Agnoprotein deletion and archetype-like RR to the phenotype of JCVCPN1 in vitro Aim 3) Characterize the prevalence of JCV infection of cortical pyramidal neurons in archival samples from PML patients and identify the CPN1 mutation using immunohistochemistry and laser capture microdissection Aim 4) Investigate JCV infection of hippocampal pyramidal neurons in immunosuppressed individuals and in patients with hippocampal sclerosis or intractable epilepsy

Public Health Relevance

JC virus infects glial cells and typically causes a disease of the white matter of the brain, called Progressive Multifocal Leukoencephalopathy. We have described a novel clinical entity caused by a JC virus variant infecting cortical pyramidal neurons. We called this disease, restricted to the gray matter of the brain, JCV encephalopathy (JCVE). We will characterize the pathogenesis of this unique JC virus variant in vitro and define the prevalence of JCV infection of pyramidal neurons in immunosuppressed individuals. We will also investigate the role of JCV infection of hippocampal neurons in immunocompetent people with intractable seizures or elderly subjects with hippocampal sclerosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS074995-02
Application #
8420424
Study Section
Clinical Neuroimmunology and Brain Tumors Study Section (CNBT)
Program Officer
Wong, May
Project Start
2012-02-15
Project End
2017-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
2
Fiscal Year
2013
Total Cost
$359,805
Indirect Cost
$148,711
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Ellis, Laura C; Koralnik, Igor J (2015) JC virus nucleotides 376-396 are critical for VP1 capsid protein expression. J Neurovirol 21:671-8
Dang, Louis; Dang, Xin; Koralnik, Igor J et al. (2014) JC polyomavirus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol 71:487-9
Siddiqi, Omar K; Ghebremichael, Musie; Dang, Xin et al. (2014) Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis 58:1771-7
Agnihotri, Shruti P; Dang, Xin; Carter, Jonathan L et al. (2014) JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology 83:727-32
Schwenk, Hayden; Ramirez-Avila, Lynn; Sheu, Shu-Hsien et al. (2014) Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J 33:e99-105
Lach, Boleslaw; Connolly, Barbara; Wuthrich, Christian et al. (2014) Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology 34:39-44
Tan, Chen Sabrina; Broge Jr, Thomas A; Ngo, Long et al. (2014) Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant 20:992-9
Agnihotri, Shruti P; Wuthrich, Christian; Dang, Xin et al. (2014) A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient. Ann Neurol 76:140-7
Chalkias, Spyridon; Dang, Xin; Bord, Evelyn et al. (2014) JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol 75:925-34
Khoury, Michael N; Alsop, David C; Agnihotri, Shruti P et al. (2014) Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol 75:659-69

Showing the most recent 10 out of 16 publications